Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050172-26-000032 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 3, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
88,423
Total Value
$593,701.49
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D&CMO | Common Stock | โ | Sep 1, 2026 | Exercise/Conversion | 16,141 | $10.42 | $168,189.22 | 16,141 | Direct | โ | View Details | |
President, R&D&CMO | Common Stock | โ | Sep 1, 2026 | Sale | 16,141 | $26.36 | $425,512.27 | 0 | Direct | โ | View Details | |
President, R&D&CMO | Common Stock | โ | Sep 1, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 20,000 | Direct | โ | View Details | |
President, R&D&CMO | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Exercise/Conversion | 16,141 | $0.00 | $0.00 | 160,662 | Direct | โ | View Details | |
President, R&D&CMO | Restricted Stock Units | Derivative | Sep 1, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 20,000 | Direct | โ | View Details |